Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Stephen Youngberg, Erin Brandt, Avantika Barve, Surendra Machineni, Christopher T. Jones, Kristina Dabovic, Catherine L. Jones & Richard A. Colvin. (2018) A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers. Journal of Drug Assessment 7:1, pages 66-74.
Read now
Read now
Vicente Gimeno-Ballester, Javier Mar, Aisling O’Leary, Róisín Adams & Ramón San Miguel. (2017) Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients. Expert Review of Gastroenterology & Hepatology 11:1, pages 85-93.
Read now
Read now
José-R. Blanco & Antonio Rivero-Juarez. (2016) HCV genotype 3: a wolf in sheep’s clothing. Expert Review of Anti-infective Therapy 14:2, pages 149-152.
Read now
Read now
Articles from other publishers (11)
Damir Garcia‐Cehic, Ariadna Rando, Francisco Rodriguez‐Frias, Josep Gregori, Juan Garcia Costa, José Antonio Carrión, Ramiro Macenlle, Javier Pamplona, Angeles Castro‐Iglesias, Angelina Cañizares, David Tabernero, Carolina Campos, Maria Buti, Juan Ignacio Esteban & Josep Quer. (2021) Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure. Journal of Viral Hepatitis 28:9, pages 1319-1324.
Crossref
Crossref
Vasilios Papastergiou, Hariklia Kranidioti & Spilios Manolakopoulos. 2021. Hepatitis C: Care and Treatment. Hepatitis C: Care and Treatment
97
117
.
Miguel García Deltoro & Carmen Ricart Olmos. (2019) Infección por el virus de la hepatitis C y nuevas estrategias de tratamiento. Enfermedades Infecciosas y Microbiología Clínica 37, pages 15-19.
Crossref
Crossref
Aparna Goel, Aijaz Ahmed & Imam Waked. 2019. Clinical Epidemiology of Chronic Liver Diseases. Clinical Epidemiology of Chronic Liver Diseases
149
170
.
Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito & Maria Cássia Mendes-Corrêa. (2017) Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de São Paulo 59:0.
Crossref
Crossref
Edward Gane, Catherine Stedman, Kiran Dole, Jin Chen, Charles Daniel Meyers, Brigitte Wiedmann, Jin Zhang, Prakash Raman & Richard A. Colvin. (2016) A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial. ACS Infectious Diseases 3:2, pages 144-151.
Crossref
Crossref
Ana I. de Ávila, Isabel Gallego, Maria Eugenia Soria, Josep Gregori, Josep Quer, Juan Ignacio Esteban, Charles M. Rice, Esteban Domingo & Celia Perales. (2016) Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir. PLOS ONE 11:10, pages e0164691.
Crossref
Crossref
Javier Ampuero. (2016) Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options. World Journal of Gastroenterology 22:22, pages 5285.
Crossref
Crossref
Stephen PiankoSteven L. FlammMitchell L. ShiffmanSonal KumarSimone I. StrasserGregory J. DoreJohn McNallyDiana M. BrainardLingling HanBrian DoehleErik MogalianJohn G. McHutchisonMordechai RabinovitzWilliam J. TownerEdward J. GaneCatherine A.M. StedmanK. Rajender ReddyStuart K. Roberts. (2015) Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection. Annals of Internal Medicine 163:11, pages 809-817.
Crossref
Crossref
Gregory T. EversonWilliam J. TownerMitchell N. DavisDavid L. WylesRonald G. NahassPaul J. ThuluvathKyle EtzkornFederico HinestrosaMyron TongMordechai RabinovitzJohn McNallyDiana M. BrainardLingling HanBrian DoehleJohn G. McHutchisonTimothy MorganRaymond T. ChungTram T. Tran. (2015) Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection. Annals of Internal Medicine 163:11, pages 818-826.
Crossref
Crossref
E. Rodríguez de Santiago, J. Martínez González, F. Gea Rodríguez & A. Albillos Martínez. (2014) Actualización en el tratamiento de la hepatitis C. Medicine - Programa de Formación Médica Continuada Acreditado 11:69, pages 4103-4111.
Crossref
Crossref